81
54
Growth Score
-7 pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
682825
Aummune designs cancer therapeutics that personalize to patient-specific disease parameters at each stage of the therapeutic pathway.
- Guy Neev: Chief Executive OfficerPast Role: Check-Cap, Chief Executive Officer
About the Company
Aummune provides cancer therapeutics intended to personalize to patient-specific disease parameters at each stage of the therapeutic pathway. The company platform addresses the unmet need for highly personalized, targeted, safe and agile therapies for widespread and life-threatening diseases, enabling cancer patients to transform their lives
through therapeutics.
